GLAXO PRICING CEFTIN COMPETITIVELY WITH LILLY's CECLOR; FDA APPROVES SECOND-GENERATION ORAL CEPHALOSPORIN ON DEC. 28; LAUNCH SCHEDULED FOR FEBRUARY

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".